"Overall, this vaccine is safe in the long term and our participants reported having fewer UTIs that were less severe," says Bob Yang, MBBS, FRCS.
John Parkinson
Advertisement
Articles by John Parkinson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
4
Nicole L. Miller, MD, FACS, on assessing patients after BPH treatment failure
5